Y
Yifan Zhou
Researcher at Huazhong University of Science and Technology
Publications - 39
Citations - 7655
Yifan Zhou is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 12, co-authored 23 publications receiving 5116 citations. Previous affiliations of Yifan Zhou include Tongji Medical College.
Papers
More filters
Journal ArticleDOI
The predictive accuracy of satellite sign for hematoma expansion in intracerebral hemorrhage: A meta-analysis.
Hang Yang,Yan Luo,Shao-li Chen,Xue-Ying Luo,Bo-Wei Li,Shengcai Chen,Yifan Zhou,Yuan-Peng Xia +7 more
TL;DR: Satellite sign exhibited moderate sensitivity and specificity for predicting hematoma expansion in patients with ICH, and further studies are needed to explore its value in clinical application.
Journal ArticleDOI
Endothelial ETS1 inhibition exacerbate blood–brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition
Yan Luo,Hang Yang,Yan Wan,Sibo Yang,Jiehong Wu,Shengcai Chen,Yanan Li,Huijuan Jin,Quan-Wei He,Dong-Ya Zhu,Yifan Zhou,Bo Hu +11 more
TL;DR: Wang et al. as mentioned in this paper identified ETS1 as a central regulator of EndMT associated with the compromise of barrier integrity, which can further induce high permeability, immune infiltration, and organ fibrosis in multiple sclerosis, thus promoting disease progression.
Journal ArticleDOI
STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells
Taylor T. Chrisikos,Yifan Zhou,Laura Maria S. Kahn,Bhakti Patel,Nina Denne,Athena Brooks,Lijian Shen,Jing Wang,Stephanie S. Watowich +8 more
TL;DR: An essential role for STAT3 is elucidated in restraining autocrine IFN-I signaling in cDC1s elicited by poly(I:C) stimulation, and novel RNA sequencing datasets are provided that will aid in further delineating inflammatory and anti-inflammatory mechanisms in c DC1s.
Journal ArticleDOI
COVID-19 vaccine acceptance and hesitancy in patients with Parkinson's disease
Yifan Zhou,Zhengyu Lin,X. Wan,Jun Liu,Jianqing Ding,Chencheng Zhang,Kang Ren,Dianyou Li,Yiwen Wu +8 more
TL;DR: The COVID-19 vaccination rate remained low in PD patients, however, most individuals understood benefits of vaccination and could help government and public health authorities to overcome the barrier to COVID/19 vaccination and improve vaccine roll-out inPD patients.
Journal ArticleDOI
STAT3 Protects Hematopoietic Stem and Progenitor Cell Function in Non-Inflamed Conditions
Bhakti Patel,Yifan Zhou,Rachel L. Babcock,Feiyang Ma,Yusra Medik,Laura Maria S. Kahn,Josue Pineda,Elizabeth M. Park,Karen Clise-Dwyer,Simona Colla,Stephanie S. Watowich +10 more
TL;DR: In this paper , the authors developed competitive mixed bone marrow (BM) chimeric mice with conditional STAT3 deletion in approximately 20% of hematopoietic cells (Figure 1a).